Has Thomas Sroka, MD received payments from drug or device companies?

Yes. Drug and device makers reported $617 in general payments to Thomas Sroka, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Sroka, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Sroka, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Sroka, MD

Radiation Oncology · Eugene, ORNPI 1700058021

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $516 of the $617 with a category attached, or 83.7%. Every reported general payment came from a single manufacturer, Siemens Medical Solutions USA, Inc..

$617in general payments, 2019–2025

Across 6 payments — averaging $102.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Siemens Medical Solutions USA, Inc.$617

$27,492in research payments, 2019–2025

Across 6 payments — averaging $4582.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AstraZeneca$27K

What the payments were for

Travel & lodging$51684%
Food & beverage$10116%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Siemens Medical Solutions USA, Inc.	6	$617

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Biograph Trinion EP CT64$461

How this compares

$617 in reported general payments places this provider in the 65th percentile of 93 radiation oncology providers in Oregon.

See all radiation oncology providers in Oregon →

Medicare billing

Part B allowed, 2024

$556,649

Medicare patients

214

Services billed

3,133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	67	$713
Oxycodone Hcl	17	$431
Levothyroxine Sodium	13	$39

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Eugene

Haidy LeeEugene$5K
Timur MitinHillsboro$58K
Marka CrittendenPortland$20K
William ArscottTigard$16K
Steven SeungPortland$11K
Joshua WalkerPortland$9K
Andrew KeePortland$7K
Brandon DyerPortland$4K
Nima NabavizadehPortland$4K
Amar SrivastavaPortland$4K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →